Investment to Accelerate Expansion Into New Specialties and Markets

投资以加速向新专业领域和新市场的扩张

KANSAS CITY, Mo.

密苏里州堪萨斯城

,

，

June 12, 2026

2026年6月12日

/PRNewswire/ -- Aton Health ('Aton' or 'the Company') today announced the closing of a Series A growth investment led by Shore Search Partners. Aton is a healthcare company that integrates research into routine patient care, helping providers participate in research programs, access broader patient populations, and generate meaningful real-world evidence without disrupting provider workflows..

/美通社/ -- Aton Health（“Aton”或“公司”）今日宣布，已完成由Shore Search Partners领投的A轮增长投资。Aton是一家将研究融入常规患者护理的医疗保健公司，帮助医疗服务提供者参与研究项目、接触更广泛的患者群体，并在不干扰其工作流程的情况下生成具有意义的真实世界证据。

The investment will support the continued expansion of Aton Health's TrialSight™ and CareSight™ platforms, entry into additional specialties and markets beyond gastroenterology, and advancements in technology, operations, and team growth.

这笔投资将支持Aton Health公司TrialSight™和CareSight™平台的持续扩展，进入胃肠病学以外的更多专科和市场，并推动技术、运营和团队发展方面的进步。

Unlike traditional clinical trial sites, Aton embeds its data collection infrastructure directly into existing specialty practices. The company supports non-interventional research initiatives designed to improve patient engagement, research accessibility, and clinical insight generation.

与传统的临床试验机构不同，Aton 将其数据收集基础设施直接嵌入到现有的专科诊所中。该公司支持旨在提高患者参与度、研究可及性和临床洞察生成的非干预性研究项目。

Tom Sanders, CEO and Co-Founder of Aton Health, said, 'Our mission is to make healthcare research more accessible, actionable, and representative. Having a sophisticated healthcare investor like Shore Search Partners see value in our platform accelerates our efforts to deliver research models that fit naturally within care delivery and provide sponsors with access to high-quality, real-world data.'.

Aton Health 首席执行官兼联合创始人汤姆·桑德斯表示：“我们的使命是让医疗研究更易于获取、更具可操作性且更具代表性。像 Shore Search Partners 这样专业的医疗投资机构认可我们平台的价值，这将加速我们交付自然融入医疗服务流程的研究模型，并为申办方提供获取高质量真实世界数据的机会。”

Cameron Perkins, Partner at Shore Search Partners, added, 'The future of clinical research depends on making participation more accessible to patients while minimizing operational burden on providers. Too often, patients are unaware of research opportunities that could provide access to innovative treatments and help advance medical knowledge.

Shore Search Partners 的合伙人 Cameron Perkins 补充道：“临床研究的未来取决于在最大限度减轻提供方运营负担的同时，提高患者参与的便利性。很多时候，患者并不了解那些可能为其提供创新治疗途径并有助于推动医学知识进步的研究机会。”

Aton is helping close that gap by embedding research into routine care through a scalable platform that expands patient access, fits naturally within clinical workflows, and generates broader and more representative real-world evidence. We look forward to supporting Tom and the team as they expand TrialSight and CareSight into additional specialties and healthcare markets.'.

Aton 正通过一个可扩展的平台，将研究嵌入常规护理中，从而帮助缩小这一差距。该平台能够扩大患者获取服务的渠道，自然融入临床工作流程，并生成更广泛、更具代表性的真实世界证据。我们期待支持 Tom 及其团队将 TrialSight 和 CareSight 拓展至更多专科领域和医疗保健市场。

Transaction Highlights

交易亮点

Aton Health closes Series A growth investment led by Shore Search Partners, an investment platform of Shore Capital Partners

Aton Health 完成由 Shore Capital Partners 旗下投资平台 Shore Search Partners 领投的 A 轮成长型融资

Investment supports continued expansion of TrialSight™ and CareSight™, Aton Health's provider-enabled research and real-world evidence platforms

投资支持Aton Health的TrialSight™和CareSight™平台的持续扩展，这两个平台是提供商赋能的研究和真实世界证据平台。

Proceeds to fund entry into additional medical specialties and healthcare markets, with ongoing investment in technology, operations, and team growth

所得资金用于拓展更多医疗专科领域和 healthcare 市场，并持续投资于技术、运营及团队发展

Aton Health enables healthcare providers to participate in non-interventional research integrated into routine patient care, supporting sponsor access to broader patient populations and real-world clinical evidence

Aton Health 使医疗保健提供者能够参与融入常规患者护理的非干预性研究，从而支持申办方接触更广泛的患者群体并获取真实世界临床证据。

Tom Sanders serves as CEO and Co-Founder of Aton Health, headquartered in Kansas City, Missouri

汤姆·桑德斯担任总部位于密苏里州堪萨斯城的Aton Health的首席执行官兼联合创始人。

Aton Health's platform screens tens of thousands of patients monthly across active research programs

Aton Health 的平台每月在各项活跃的研究项目中为数万名患者进行筛查

More than 5,000 patients are actively enrolled across Aton Health's studies

超过5,000名患者正在积极参与Aton Health的各项研究

About Aton Health

关于 Aton Health

Aton Health is a healthcare company that integrates research into routine patient care, enabling scalable, provider-centered research and evidence generation. Through platforms including TrialSight™ and CareSight™, Aton helps healthcare providers participate in non-interventional research programs while supporting sponsors with access to broader patient populations and meaningful real-world clinical insights.

Aton Health 是一家将研究融入常规患者护理的医疗健康公司，从而实现可扩展、以提供者为中心的研究和证据生成。通过包括 TrialSight™ 和 CareSight™ 在内的平台，Aton 帮助医疗保健提供者参与非干预性研究项目，同时支持申办方接触更广泛的患者群体并获得有意义的真实世界临床洞察。

The company's mission is to make healthcare research more accessible, actionable, and integrated into routine patient care. To learn more, visit .

公司的使命是让医疗研究更易于获取、更具可操作性，并融入常规患者护理中。欲了解更多信息，请访问。

www.atonhealth.com

www.atonhealth.com

.

。

About Shore Search Partners

关于 Shore Search Partners

Shore Capital, a Chicago-based private equity firm with an office in Nashville, is an investor in lower-middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore's strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio.

Shore Capital 是一家总部位于芝加哥、在纳什维尔设有办公室的私募股权公司，专注于投资医疗保健、食品饮料、商业服务、工业和房地产行业的中小型市场企业。Shore 的战略是通过提供资本支持、世界级的董事会和运营资源，以及在整个投资组合中无与伦比的 networking、发展和共享学习机会，帮助管理合作伙伴以更低的风险实现更快的增长。

From 2020-2025, Shore received recognition from Inc. Magazine as a 6x Top Founder Friendly Investor and by Pitchbook Research for leading U.S. Private Equity deal volume for the past 10 years, from 2015-2024. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders.

2020年至2025年间，Shore连续六次被《Inc.》杂志评为“对创始人最友好的投资者”，并被Pitchbook Research评为2015年至2024年过去十年间美国私募股权交易量的领军者。Shore专注于投资那些拥有卓越管理团队、稳定现金流，并通过行业整合和有机增长具备巨大增值潜力的成熟优质私营企业，从而为股东创造价值。

Shore has approximately $17 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. To learn more about Shore Capital Partners, and for more information on these awards and investment platforms, please visit .

Shore 管理着约 170 亿美元的资产，并为其他投资平台提供业务和运营咨询服务。如需了解更多关于 Shore Capital Partners 的信息，以及这些奖项和投资平台的详细信息，请访问 。

www.shorecp.com

www.shorecp.com

.

。

Media Contact

媒体联系人

Jim Radosevic

吉姆·拉多塞维奇

Strategic Communications for Aton Health

Aton Health 的战略传播

[email protected]

[email protected]

SOURCE Aton Health

来源 Aton Health

21

二十一

%

%

more press release views with

更多新闻稿浏览量，使用

Request a Demo

申请演示